Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.04M | $ 4.01M | $ 4.74M | $ 1.08M | $ 71.00K |
| Gross Profit | $ 1.04M | $ 4.01M | $ 3.35M | $ -184.00K | $ -56.93M |
| Operating Income | $ -338.85M | $ -222.61M | $ -167.88M | $ -107.70M | $ -74.95M |
| EBITDA | $ -338.85M | $ -221.51M | $ -166.90M | $ -106.78M | $ -72.59M |
| Net Income | $ -298.41M | $ -214.53M | $ -159.95M | $ -106.72M | $ -72.86M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.35B | $ 558.55M | $ 334.43M | $ 333.71M | $ 170.88M |
| Total Assets | $ 1.43B | $ 635.35M | $ 352.18M | $ 351.01M | $ 183.44M |
| Total Debt | $ 51.72M | $ 51.73M | $ 2.02M | $ 3.07M | $ 4.01M |
| Net Debt | $ -212.82M | $ -3.17M | $ -30.65M | $ -197.62M | $ -89.07M |
| Total Liabilities | $ 109.79M | $ 96.25M | $ 35.85M | $ 19.07M | $ 14.53M |
| Stockholders' Equity | $ 1.32B | $ 539.11M | $ -439.17M | $ -275.25M | $ -167.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -229.81M | $ -171.00M | $ -116.86M | $ -89.02M | $ -62.21M |
| Operating Cash Flow | $ -225.97M | $ -166.31M | $ -115.20M | $ -88.59M | $ -62.03M |
| Investing Cash Flow | $ -574.82M | $ -200.41M | $ -173.98M | $ -56.48M | $ 217.00K |
| Financing Cash Flow | $ 1.01B | $ 388.94M | $ 121.96M | $ 252.68M | $ 114.57M |